For Health and Medical Life Sciences Industry The Accelerator Program Access Grants (APAG) provides funding for up to five senior or executive level managers to travel to and participate in… Continue reading DEADLINE: Accelerator Program Access Grants
CUREator+ will provide SMEs (SMEs) with access to investment capital, commercial guidance, international expert networks, and hands-on support and mentorship to drive the translation and commercialisation of their opportunities. In addition to program oversight, SMEs will be supported to secure follow-on funding and facilitate their continued development. This program aims to support the development of:… Continue reading DEADLINE: CUREator+ Program Round 2
The Innovation Seed Fund seeks to build Western Australia’s health and medical innovation pipeline by providing funding to Western Australian innovators to help develop and commercialise novel process, products and/or services that demonstrate a positive impact on the health and wellbeing of the WA community. The funding will be used to support the validation of… Continue reading DEADLINE: Innovation Seed Fund 24-25
This program provides small to medium sized enterprises with funding to develop innovative solutions for government policy and service delivery challenges. This round focuses on a cyber security challenge identified by government. What do you get? Grants from $50,000 to $100,000 for a Feasibility project. If your Feasibility project is successful, you may receive up… Continue reading DEADLINE: Business Research and Innovation Initiative (BRII) – Australian Cyber Security Strategy Challenge
The Solar SunShot program aims to support innovative solar PV manufacturing facilities in Australia across the solar supply chain. The total funding allocated for the program is up to $1 billion (total funding allocation). The amount of funding allocated for a funding round will be specified in the relevant funding announcement. Two funding rounds have… Continue reading DEADLINE: Solar Sunshot Program (ARENA) Round 1A
